Pharmaceutical Stocks

ICPT: Time to Catch a Rising Star With Intercept Stock?

It's never too late to invest in a long-term winner, and pharmaceutical player Intercept is on a long-term run. Here's why you should join the race... More 

ACT: Actavis’s Growth Potential Anything But Generic

Pharmaceutical company Actavis is at the forefront on the production of biologic drugs, and stands to profit from them well into the future. It's a buy! More 

ICPT – Why Intercept Pharmaceuticals Just Exploded

Intercept Pharmaceuticals says a trial of its liver drug was halted early after the drug met its primary goal, sending ICPT stock up more than 280% on Thursday. More 

Sequenom – SQNM Stock Soars on Genetic Testing Patent

Shares of Sequenom climbed almost 9% on Thursday after the company said it had been awarded a European patent for a genetic testing process. More 

GSK Stock Inches Higher on Accelerated FDA Approval

GlaxoSmithKline said that the FDA had approve a combination of two drugs to treat melanoma, sending GSK stock up modestly on Thursday. More 

OXBT Stock – Why Oxygen Biotherapeutics Boomed Over 30%

Oxygen Biotherapeutics has published the protocols for a phase 3 trial of its new cardiac drug, sending OXBT stock up sharply. More 

FDA Rejects Sanofi Multiple Sclerosis Drug

Lemtrada, a drug from Sanofi meant to treat multiple sclerosis, has been rejected by the FDA, which has called for more clinical trials. More 

The One Stock You Must Sell Now Is Eli Lilly

Eli Lilly's in a position where patents are coming off faster than new products are coming on board, a bad sign for a stock you should sell right now.... More 

5 Pharma Stocks to Buy for Big Dividends

Drugmakers aren't known for big dividends, but the pharmaceutical industry can actually offer something for income investors. More 

AMRN Stock Slides as CEO of Troubled Company Quits

The abrupt announcement of the retirement of drug-maker Amarin's chairman and CEO early next year sent AMRN stock down sharply. More